Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

AI giant Anthropic buys Coefficient Bio for $400m

 April 7, 2026

Pharmaphorum

Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.

M&A / DealsRead full story

Post navigation

Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3 →
← Sanofi immune drug hopeful posts mixed results in mid-stage tests

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com